Pyxis Oncology
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2019-01-01
- Employees
- 50
- Market Cap
- $216.9M
- Website
- http://www.pyxisoncology.com
- Introduction
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
- First Posted Date
- 2025-01-28
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Pyxis Oncology, Inc
- Target Recruit Count
- 200
- Registration Number
- NCT06795412
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸University of Texas - M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸NEXT Virginia, Fairfax, Virginia, United States
Study of PYX-201 in Solid Tumors
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Pyxis Oncology, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT05720117
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸SCRI - HealthOne Denver, Denver, Colorado, United States
🇺🇸SCRI - Florida Cancer Specialists, Sarasota, Florida, United States
Study of PYX-106 in Solid Tumors
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Pyxis Oncology, Inc
- Target Recruit Count
- 47
- Registration Number
- NCT05718557
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸University of California San Diego, La Jolla, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States